Review



polylinker sequences  (Integrated DNA Technologies)


Bioz Verified Symbol Integrated DNA Technologies is a verified supplier
Bioz Manufacturer Symbol Integrated DNA Technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Integrated DNA Technologies polylinker sequences
    Polylinker Sequences, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/10__1128_slash_mcb__20__18__7037___7048__2000-79-21-9?v=Integrated+DNA+Technologies
    Average 94 stars, based on 11 article reviews
    polylinker sequences - by Bioz Stars, 2026-06
    94/100 stars

    Images



    Similar Products

    99
    TaKaRa polylinker sequence
    Polylinker Sequence, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/pm38232124-232-1-36?v=TaKaRa
    Average 99 stars, based on 1 article reviews
    polylinker sequence - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    94
    Integrated DNA Technologies polylinker sequences
    Polylinker Sequences, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/10__1128_slash_mcb__20__18__7037___7048__2000-79-21-9?v=Integrated+DNA+Technologies
    Average 94 stars, based on 1 article reviews
    polylinker sequences - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    90
    Promega pvu ii restriction fragment containing polylinker sequences plasmid pgem5zf
    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid <t>pGEM5Zf</t> (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.
    Pvu Ii Restriction Fragment Containing Polylinker Sequences Plasmid Pgem5zf, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/pmc06081617-274-66-68?v=Promega
    Average 90 stars, based on 1 article reviews
    pvu ii restriction fragment containing polylinker sequences plasmid pgem5zf - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Promega polylinker sequence from pgl3-basic
    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid <t>pGEM5Zf</t> (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.
    Polylinker Sequence From Pgl3 Basic, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/pmc02844622-422-11-12?v=Promega
    Average 90 stars, based on 1 article reviews
    polylinker sequence from pgl3-basic - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher gateway® destination vector, pfastbacmam-2-rfa (a variant of the plasmid described in [ ], containing additional polylinker sequences)
    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid <t>pGEM5Zf</t> (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.
    Gateway® Destination Vector, Pfastbacmam 2 Rfa (A Variant Of The Plasmid Described In [ ], Containing Additional Polylinker Sequences), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/pmc02669217-29-27-46?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    gateway® destination vector, pfastbacmam-2-rfa (a variant of the plasmid described in [ ], containing additional polylinker sequences) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Addgene inc fire lab gfp vector polylinker sequence
    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid <t>pGEM5Zf</t> (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.
    Fire Lab Gfp Vector Polylinker Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/pm18402933-59-30-36?v=Addgene+inc
    Average 90 stars, based on 1 article reviews
    fire lab gfp vector polylinker sequence - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    TranScrip Partners transcrip- tion terminator and polylinker sequences
    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid <t>pGEM5Zf</t> (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.
    Transcrip Tion Terminator And Polylinker Sequences, supplied by TranScrip Partners, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/10__1128_slash_jb__01279___06-203-19-15?v=TranScrip+Partners
    Average 90 stars, based on 1 article reviews
    transcrip- tion terminator and polylinker sequences - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    86
    TaKaRa polylinker sequence 5
    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid <t>pGEM5Zf</t> (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.
    Polylinker Sequence 5, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polylinker+sequences/pm12767060-43-16-37?v=TaKaRa
    Average 86 stars, based on 1 article reviews
    polylinker sequence 5 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    Image Search Results


    Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid pGEM5Zf (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.

    Journal: Gene Expression

    Article Title: Role of Saccharomyces cerevisiae Rap1 protein in Ty1 and Ty1-mediated transcription

    doi:

    Figure Lengend Snippet: Factor binding to a Ty1 fragment I (approximately 50 bp) containing either a wild-type (I; lanes 1–4) or mutant (I*R; lane 5) RAP1 binding site and to a 22 bp oligonucleotide containing the Ty1 RAP1 binding site (lanes 8–11). Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820; lanes 1–5, 9) or rap1-1 (JF1165; lane 10) extracts. The rap1-1 strain was transformed with the RAP1 deletion plasmid pBG51 (see Materials and Methods), and extracts were prepared from cultures grown at room temperature and shifted to 37°C (lane 10). Reactions were performed in the absence of specific competitor (none) or with a 50-fold molar excess of fragment I (lane 2), oligonucleotide duplex containing the RAP1-binding site from the TEF2 gene (TEF2; lane 3), or a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid pGEM5Zf (Promega; lane 4). Positions of free probe and complex 1 (I-1 or RBSTy1-1) are indicated to the left of the autoradiogram. In lanes 6, 7, and 8, the extract was omitted. Lanes 1–7 and lanes 8–10 are taken from separate gels. Note also that a different radiolabeled probe was used in the two experiments.

    Article Snippet: Reactions were performed in the absence of competitor (–; lanes 1, 5, and 8); or in the presence of a 50-fold molar excess of fragment D (lane 2); oligonucleotide duplex containing the RAP1 binding site from the TEF2 gene (TEF2; lanes 3, 9); oligonucleotide duplex containing the palindromic Mcm1 binding site (PAL; lane 4); a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid pGEM5Zf (Promega; lanes 7, 10); or fragment D* R containing a mutation in the RAP1 binding site (lane 6).

    Techniques: Binding Assay, Mutagenesis, Transformation Assay, Plasmid Preparation

    Factor binding to Ty1 fragment D containing either a wild-type (D) or a mutant (D*R) RAP1 binding site. Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820) or mcm1-1 (JF1096) strains. Reactions were performed in the absence of competitor (–; lanes 1, 5, and 8); or in the presence of a 50-fold molar excess of fragment D (lane 2); oligonucleotide duplex containing the RAP1 binding site from the TEF2 gene (TEF2; lanes 3, 9); oligonucleotide duplex containing the palindromic Mcm1 binding site (PAL; lane 4); a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid pGEM5Zf (Promega; lanes 7, 10); or fragment D*R containing a mutation in the RAP1 binding site (lane 6). In lanes 11 and 12, extract was omitted. Positions of the free probe, complex D-1, D-2, and D-3 are indicated on each side of the autoradiogram. To the right is a schematic of the proteins known to be present in each complex.

    Journal: Gene Expression

    Article Title: Role of Saccharomyces cerevisiae Rap1 protein in Ty1 and Ty1-mediated transcription

    doi:

    Figure Lengend Snippet: Factor binding to Ty1 fragment D containing either a wild-type (D) or a mutant (D*R) RAP1 binding site. Binding reaction mixtures contained 2–4 μg of protein from wild-type (JF820) or mcm1-1 (JF1096) strains. Reactions were performed in the absence of competitor (–; lanes 1, 5, and 8); or in the presence of a 50-fold molar excess of fragment D (lane 2); oligonucleotide duplex containing the RAP1 binding site from the TEF2 gene (TEF2; lanes 3, 9); oligonucleotide duplex containing the palindromic Mcm1 binding site (PAL; lane 4); a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid pGEM5Zf (Promega; lanes 7, 10); or fragment D*R containing a mutation in the RAP1 binding site (lane 6). In lanes 11 and 12, extract was omitted. Positions of the free probe, complex D-1, D-2, and D-3 are indicated on each side of the autoradiogram. To the right is a schematic of the proteins known to be present in each complex.

    Article Snippet: Reactions were performed in the absence of competitor (–; lanes 1, 5, and 8); or in the presence of a 50-fold molar excess of fragment D (lane 2); oligonucleotide duplex containing the RAP1 binding site from the TEF2 gene (TEF2; lanes 3, 9); oligonucleotide duplex containing the palindromic Mcm1 binding site (PAL; lane 4); a 465 bp Pvu II restriction fragment containing polylinker (PL) sequences from plasmid pGEM5Zf (Promega; lanes 7, 10); or fragment D* R containing a mutation in the RAP1 binding site (lane 6).

    Techniques: Binding Assay, Mutagenesis, Plasmid Preparation